Notice Number: NOT-DA-05-001 (This notice has been superseded by NOT-DA-05-005)

Key Dates
Release Date: October 28, 2004

Purpose

This Notice regarding the National Institutes of Health (NIH) Career Development Program Announcements (K Awards) is intended to provide additional information for potential applicants on the unique aspects of National Institute on Drug Abuse (NIDA) career development programs. This supersedes the one dated August 5, 1999. The NIH program announcements addressed in this Notice are the following:

PA-00-019: Mentored Research Scientist Development Award (K0l)
PA-00-020: Independent Scientist Award (K02)
PA-00-021: Senior Scientist Award (K05)
PA-00-003: Mentored Clinical Scientist Development Award (K08)
PAR-02-076: Mentored Clinical Scientists Development Program Award (K12)
PA-00-004: Mentored Patient-Oriented Research Career Development Award (K23)
PA-04-107: Midcareer Investigator Award in Patient-Oriented Research (K24)
PA-02-127: Mentored Quantitative Research Career Development Award (K25)

The guidelines and procedures outlined in NIH program announcements must be followed closely when an application is being prepared for submission to the NIDA, Particular attention should be paid to the purpose of each award mechanism, its eligibility requirements, and its review considerations.

Note: This policy is effective and applicable only to new, competing applications submitted after February 1, 2005.

Additional Information for NIDA Applicants

The RESEARCH OBJECTIVES section of each program announcement should be followed carefully during the preparation of an application. Note especially that differences exist among various NIH Institutes regarding allowable costs. The unique aspects of NIDA allowable costs, specifically in the categories of salary (all Ks) and research development support (K01, K08, K23, K25), are listed below.

Salary (K01, K02, K05, K08, K12, K23, K24, K25)

This policy applies to all new (type 1), competitive renewal (type 2), and non-competitive renewal (type 5) applications. The NIDA contribution to the principal investigator's salary is geared to institutional base salary as follows:

Research Development Support (K01, K08, K23, K24, K25)

NIDA allows for funds up to $50,000 per year for research-related costs as outlined in each program announcement--examples include supplies, equipment, technical personnel, travel, and statistical services. [Note: This new amount is effective only for new, competing applications received after February 1, 2005).

Research Support (K02, K05)

For the K02 and K05 awards, NIDA allows for funds up to $25,000 per year for those applications from individuals who are engaged in predominantly theoretical work, such as modeling or computer simulation, as outlined in each program announcement.

Renewals

K01, K08, K23, K25 Awards:

Support for the K01, K08, K23, K25 awards are limited to one term of 3 to 5 years and are further restricted to one mentored career award per individual.

K02 and K24:

The Independent Scientist Award (K02) and Midcareer Investigator Award in Patient-Oriented Research (K24) are renewable one time only.

Inquiries:

Consultation with NIDA staff is encouraged especially during the planning phase of the application. Below are the names of the NIDA staff who can provide further information:

NIDA Institute Coordinators

Susan Weiss, Ph.D.
Coordinator, NIDA Research Training Committee
Office of Science Policy and Communications
(301) 443-6071
(301) 480-2485 ( fax)
E-mail: [email protected]

Suman A. Rao, Ph.D.
Deputy Coordinator, NIDA Research Training Committee
Office of Science Policy and Communications
(301) 443-6071
(301) 480-2485 (fax)
E-mail: [email protected]

For Programmatic Issues:

Division of Basic Neurosciences and Behavioral Research

Charles W. Sharp, Ph.D.
(301) 443-1887
(301) 594-6043 (fax)
E-mail: [email protected]

Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Jamie Biswas, Ph.D.
(301) 443-8494
(301) 443-9649 (fax)
E-mail: [email protected]

Division of Epidemiology, Services, and Prevention Research

William Bukoski, Ph.D.
(301) 402-1526
(301) 402-2636 (fax)
E-mail: [email protected]

Division of Clinical Neuroscience, Development, and Behavioral Treatment

Dorynne Czechowicz, Ph.D.
(301) 443-2237
(301) 443-6814 (fax)
E-mail: [email protected]

For Review Issues:

Office of Extramural Affairs

Mark Swieter, Ph.D.
(301) 435-1389
(301) 443-0538 (fax)
E-mail: [email protected]

Eliane Lazar-Wesley, Ph.D.
(301) 451-4530
(301) 443-0538 (fax)
E-mail: [email protected]

For Grants Management Issues:

Gary Fleming, J.D., M.A.
Chief, Grants Management Officer
(301) 443-6710
(301) 594-6849 (fax)
E-mail: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®